| Proteogenomic characterization of pancreatic ductal adenocarcinoma L Cao, C Huang, DC Zhou, Y Hu, TM Lih, SR Savage, K Krug, DJ Clark, ... Cell 184 (19), 5031-5052. e26, 2021 | 271 | 2021 |
| Spatially restricted drivers and transitional cell populations cooperate with the microenvironment in untreated and chemo-resistant pancreatic cancer D Cui Zhou, RG Jayasinghe, S Chen, JM Herndon, MD Iglesia, P Navale, ... Nature genetics 54 (9), 1390-1405, 2022 | 78 | 2022 |
| Histopathologic and proteogenomic heterogeneity reveals features of clear cell renal cell carcinoma aggressiveness Y Li, TSM Lih, SM Dhanasekaran, R Mannan, L Chen, M Cieslik, Y Wu, ... Cancer Cell 41 (1), 139-163. e17, 2023 | 53 | 2023 |
| Mycena genomes resolve the evolution of fungal bioluminescence HM Ke, HH Lee, CYI Lin, YC Liu, MR Lu, JWA Hsieh, CC Chang, PH Wu, ... Proceedings of the National Academy of Sciences 117 (49), 31267-31277, 2020 | 33 | 2020 |
| Polybenzyl glutamate biocompatible scaffold promotes the efficiency of retinal differentiation toward retinal ganglion cell lineage from human-induced pluripotent stem cells TC Chen, PY She, DF Chen, JH Lu, CH Yang, DS Huang, PY Chen, ... International journal of molecular sciences 20 (1), 178, 2019 | 23 | 2019 |
| Behavioral epigenetics: perspectives based on experience-dependent epigenetic inheritance YY Pang, RJH Lu, PY Chen Epigenomes 3 (3), 18, 2019 | 12 | 2019 |
| ATACgraph: profiling genome-wide chromatin accessibility from ATAC-seq RJH Lu, YT Liu, CW Huang, MR Yen, CY Lin, PY Chen Frontiers in Genetics 11, 618478, 2021 | 9 | 2021 |
| Bioinformatics of epigenetic data generated from next-generation sequencing CYL Sheu, YC Huang, PY Lin, GJ Lin, PY Chen Epigenetics in human disease, 37-82, 2024 | 8 | 2024 |
| Construction and characterization of a knock-down RNA interference line of OsNRPD1 in rice (Oryza sativa ssp japonica cv Nipponbare) E Debladis, TF Lee, YJ Huang, JH Lu, SM Mathioni, MC Carpentier, ... Philosophical Transactions of the Royal Society B 375 (1795), 20190338, 2020 | 8 | 2020 |
| Integrative multi-omic cancer profiling reveals DNA methylation patterns associated with therapeutic vulnerability and cell-of-origin WW Liang, RJH Lu, RG Jayasinghe, SM Foltz, E Porta-Pardo, Y Geffen, ... Cancer cell 41 (9), 1567-1585. e7, 2023 | 7 | 2023 |
| The histone variant H2A.W cooperates with chromatin modifications and linker histone H1 to maintain transcriptional silencing of transposons in Arabidopsis P Bourguet, R Yelagandula, TK To, A Osakabe, A Alishe, RJH Lu, ... bioRxiv, 2022.05. 31.493688, 2022 | 7 | 2022 |
| Epigenetic regulation during cancer transitions across 11 tumour types NV Terekhanova, A Karpova, WW Liang, A Strzalkowski, S Chen, Y Li, ... Nature 623 (7986), 432-441, 2023 | 6 | 2023 |
| Proteogenomic insights suggest druggable pathways in endometrial carcinoma Y Dou, L Katsnelson, MA Gritsenko, Y Hu, B Reva, R Hong, YT Wang, ... Cancer cell 41 (9), 1586-1605. e15, 2023 | 6 | 2023 |
| Blimp-1 molds the epigenetic architecture of IL-21–mediated autoimmune diseases through an autoregulatory circuit YW Liu, SH Fu, MW Chien, CY Hsu, MH Lin, JL Dong, RJH Lu, YJ Lee, ... JCI insight 7 (11), 2022 | 6 | 2022 |
| MethylC-analyzer: a comprehensive downstream pipeline for the analysis of genome-wide DNA methylation RJH Lu, PY Lin, MR Yen, BH Wu, PY Chen Botanical studies 64 (1), 1, 2023 | 3 | 2023 |
| Neoplastic cell enrichment of tumor tissues using coring and laser microdissection for proteomic and genomic analyses of pancreatic ductal adenocarcinoma QK Li, Y Hu, L Chen, M Schnaubelt, D Cui Zhou, Y Li, RJH Lu, ... Clinical Proteomics 19 (1), 36, 2022 | 3 | 2022 |
| Assessing chromatin accessibility in maize using ATAC-seq YJ Lee, P Chang, JH Lu, PY Chen, CJR Wang BioRxiv, 526079, 2019 | 3 | 2019 |
| Transcriptome analysis of Dnmt3l knock-out mice derived multipotent mesenchymal stem/stromal cells during osteogenic differentiation CY Yang, RJH Lu, MK Lee, FSH Hsiao, YP Yen, CC Cheng, PS Hsu, ... Frontiers in Cell and Developmental Biology 9, 615098, 2021 | 2 | 2021 |
| Integrated Clinico-Pathological and Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma by the Clinical Proteomic Tumor Analysis Consortium (CPTAC) R Mannan, Y Li, S Chen, L Chen, Y Zhang, Y Wu, N Hosseini, ... LABORATORY INVESTIGATION 102 (SUPPL 1), 630-630, 2022 | 1 | 2022 |
| Differential chromatin accessibility and transcriptional dynamics define breast cancer subtypes and their lineages MD Iglesia, RG Jayasinghe, S Chen, NV Terekhanova, JM Herndon, ... bioRxiv, 2023.10. 31.565031, 2023 | | 2023 |
Pao-Yang ChenAcademia Sinica, Taipei, TaiwanVerified email at gate.sinica.edu.tw
